Grant: CIHR Fellowship
Direct Payment
$150,000.00
Combinatorial Gene Therapy for the Treatment of Early- and Late-Stage Osteoarthritis
EF 2013-14
Résumé
Articular cartilage is the smooth, white connective tissue located at the ends of bones within synovial joints such as the knee. Osteoarthritis is a degenerative disease characterized by articular cartilage loss and joint inflammation that result in severe pain and disability. Though one in 10 Canadian adults suffers from osteoarthritis, there are no therapies available to prevent or reverse its progression. The goal of my research is to develop treatments for osteoarthritis using a state-of-the-art technique known as gene therapy - an approach that allows DNA to be introduced into an individual's cells to alter their behavior and treat disease. This new approach will be developed using a mouse model of osteoarthritis. Specifically, my research will focus on reducing inflammation and promoting cartilage repair by transferring two genes simultaneously into the joints of mice with osteoarthritis. It is expected that this therapy will result in improved joint function, reduced pain and improved articular cartilage health compared to untreated mice. If shown to be safe and effective in animal models, the findings of this research could provide an effective means to treat the progression of osteoarthritis in human patients.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Texas, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
301198
Name
Grol Matthew W
Region
Texas
Country
United States of America
Orgtype
Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Combinatorial Gene Therapy for the Treatment of Early- and Late-Stage Osteoarthritis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Articular Cartilage; Chondrocytes; Gene Therapy; Helper-Dependent Adenovirus; High-Resolution Phase-Contrast Microct; Interleukin 1 Receptor Antagonist; Osteoarthritis; Proteoglycan 4; Transcriptional Profiling
Abstract
Articular cartilage is the smooth, white connective tissue located at the ends of bones within synovial joints such as the knee. Osteoarthritis is a degenerative disease characterized by articular cartilage loss and joint inflammation that result in severe pain and disability. Though one in 10 Canadian adults suffers from osteoarthritis, there are no therapies available to prevent or reverse its progression. The goal of my research is to develop treatments for osteoarthritis using a state-of-the-art technique known as gene therapy - an approach that allows DNA to be introduced into an individual's cells to alter their behavior and treat disease. This new approach will be developed using a mouse model of osteoarthritis. Specifically, my research will focus on reducing inflammation and promoting cartilage repair by transferring two genes simultaneously into the joints of mice with osteoarthritis. It is expected that this therapy will result in improved joint function, reduced pain and improved articular cartilage health compared to untreated mice. If shown to be safe and effective in animal models, the findings of this research could provide an effective means to treat the progression of osteoarthritis in human patients.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Grol, Matthew W
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~